Skip to main content

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

Completed · Phase 2 · NCT05063539

Conditions: Alzheimer Disease

At a glance

Research payments reported, 2025
$956,554
U.S. investigators named
37
Sites paid
42
Planned or actual enrollment
327

About the trial

Sponsor
Eli Lilly and Company
Tested
LY3372689 (drug), LY3372689 (drug), Placebo (drug)
Dates
Started 2021-09-16; completion 2025-05-22
Results posted
Yes

The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's Disease

From ClinicalTrials.gov, last updated 2026-06-12. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $956,554 in research payments for this study in 2025 (65 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Tandem Intermediate LLC $252,603
  • Adams Clinical Inc $104,010
  • Irvine Center for Clinical Research Inc $94,328
  • Elligo Health Research Inc $77,992
  • University of Texas Health $70,593
  • Charter Research LLC $57,423
  • Sharp Mesa Vista Hospital $46,477
  • Institute for Neurodegenerative Disorders $38,749
  • Erg Holding Co LLC DBA St Louis Clinical Trials LLC $28,622
  • Keystone Clin Studies $24,392
  • Suncoast Clinical Research $23,942
  • K2 Medical Research LLC $21,007
  • Visionary Investigators Network $20,472
  • Advanced Memory Research Institute of Nj PC $18,535
  • Renstar Inc $13,228
  • Research Foundation of State Univ of Ny $12,152
  • $11,430
  • Headlands Eastern Ma LLC $8,727
  • Jem Headlands LLC $6,900
  • Invicro $6,234
  • Merritt Island Medical Research LLC $4,596
  • Rhode Island Mood and Memory Research $3,600
  • Neurology Offices of South Florida, PLLC $2,929
  • Neuropsychiatric Associates of Southwest Fl PA $1,484
  • Univ of Tx Health Sciences Center at San Antonio $1,479
  • Adams Clinical LLC $1,105
  • Brain Matters Research Inc $754
  • Donald S Marks MD PC $478
  • University of Cincinnati Physicians $458
  • Clinical Trial Source LLC $415
  • Kerwin Research Center LLC $386
  • North County Neurology Associates $358
  • Alicia Cabrera $290
  • Jem Research LLC $223
  • Northern Light Eastern Maine Medical Center, ME $38
  • Imic Inc $36
  • Medvadis Research Corp LLC $36
  • Brainstorm Research $33
  • Abington Neurological Associates LTD $17
  • New York University $8
  • Neuro PAin Medical Center Inc $6
  • Josephson Wallack Munshower Neurology $6
  • Activmed Practices and Research Inc $4

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.